Skip to content

Insider · CIK 0001808968

Matthew B. Klein

ceoofficerdirector

Files at PTCT (PTC THERAPEUTICS, INC.), CLPT (ClearPoint Neuro, Inc.). First filing Jan 3, 2025, latest Apr 24, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $1.1M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

PTCT: PTC THERAPEUTICS, INC.

PTCTOct 9, 2026 · close 64.70

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
16Weak
PTCTsell10b5-1
PTC THERAPEUTICS, INC.
$137k
2,804 shares
-1%+49% from low-16% from high
36Weak
PTCTsell 610b5-1
PTC THERAPEUTICS, INC.
$390k
7,792 shares
-3%+56% from low-3% from high
32Weak
PTCTsell 410b5-1
PTC THERAPEUTICS, INC.
$204k
4,544 shares
-2%+38% from low-14% from high
35Weak
PTCTsell 410b5-1
PTC THERAPEUTICS, INC.
$374k
8,279 shares
-4%+40% from low-13% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 22, 2025CLPT
ClearPoint Neuro, Inc.
AGrant or award
Restricted Stock Unitsderivative
+12,417$0.00$012,417May 23, 2025
May 16, 2025CLPT
ClearPoint Neuro, Inc.
MOption exercise
Common Stock
+21,093--50,518May 19, 2025
May 16, 2025CLPT
ClearPoint Neuro, Inc.
MOption exercise
Restricted Stock Unitsderivative
-21,093--0May 19, 2025
Apr 22, 2025PTCT
PTC THERAPEUTICS, INC.
SOpen-market sale
Common Stock10b5-1
-2,804$48.74$137k273,234Apr 24, 2025
Feb 19, 2025PTCT
PTC THERAPEUTICS, INC.
SOpen-market sale
Common Stock10b5-1
-3,897$50.10$195k279,933Feb 21, 2025
Feb 20, 2025PTCT
PTC THERAPEUTICS, INC.
SOpen-market sale
Common Stock10b5-1
-3,895$50.12$195k276,038Feb 21, 2025
Jan 7, 2025PTCT
PTC THERAPEUTICS, INC.
SOpen-market sale
Common Stock10b5-1
-2,142$45.34$97k286,232Jan 10, 2025
Jan 8, 2025PTCT
PTC THERAPEUTICS, INC.
SOpen-market sale
Common Stock10b5-1
-2,402$44.50$107k283,830Jan 10, 2025
Jan 3, 2025PTCT
PTC THERAPEUTICS, INC.
AGrant or award
Common Stock
+70,000$0.00$0288,374Jan 7, 2025
Jan 3, 2025PTCT
PTC THERAPEUTICS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+175,000$0.00$0175,000Jan 7, 2025
Dec 31, 2024PTCT
PTC THERAPEUTICS, INC.
SOpen-market sale
Common Stock10b5-1
-8,279$45.16$374k217,528Jan 3, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Matthew B. Klein: insider trades and track record | InsiderTell